Progyny, Inc. Total Liabilities and Equity
Progyny, Inc. (PGNY) had Total Liabilities and Equity of $715.84 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-07
- 2026-06-30: Liabilities and Equity $715.84M.
- 2026-03-31: Liabilities and Equity $698.34M.
- 2025-12-31: Liabilities and Equity $742.43M.
- 2025-09-30: Liabilities and Equity $795.23M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $715.84M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $698.34M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $742.43M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $795.23M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $760.95M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $730.28M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $607.10M 10-K · filed 2026-02-27 |
| 2024-09-30 | $659.97M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $698.63M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $794.30M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $756.62M 10-K · filed 2025-03-03 |
| 2023-09-30 | $726.51M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $681.54M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $649.72M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $542.99M 10-K · filed 2024-02-29 |
| 2022-09-30 | $510.44M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $462.88M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $415.52M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $358.06M 10-K · filed 2023-03-01 |
| 2021-09-30 | $336.68M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $312.07M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $294.59M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $253.93M 10-K · filed 2022-03-01 |
| 2020-09-30 | $202.05M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $177.55M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $180.15M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $150.43M 10-K · filed 2021-03-01 |
| 2019-09-30 | $72.55M 10-Q · filed 2019-12-06 |
| 2018-12-31 | $41.32M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |